CN109069687A - A kind of antibacterial dressing and the preparation method and application thereof - Google Patents
A kind of antibacterial dressing and the preparation method and application thereof Download PDFInfo
- Publication number
- CN109069687A CN109069687A CN201680079420.0A CN201680079420A CN109069687A CN 109069687 A CN109069687 A CN 109069687A CN 201680079420 A CN201680079420 A CN 201680079420A CN 109069687 A CN109069687 A CN 109069687A
- Authority
- CN
- China
- Prior art keywords
- dressing
- antibacterial
- ammonium salt
- added
- quaternary ammonium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 88
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 47
- -1 quaternary ammonium salt compound Chemical class 0.000 claims abstract description 31
- 239000002253 acid Substances 0.000 claims abstract description 30
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 25
- 239000000872 buffer Substances 0.000 claims abstract description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 239000000203 mixture Substances 0.000 claims abstract description 19
- 239000003242 anti bacterial agent Substances 0.000 claims abstract description 16
- 238000005576 amination reaction Methods 0.000 claims abstract description 14
- 239000003381 stabilizer Substances 0.000 claims abstract description 11
- 239000002904 solvent Substances 0.000 claims abstract description 6
- 239000000243 solution Substances 0.000 claims description 47
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid group Chemical group C(CC(O)(C(=O)O)CC(=O)O)(=O)O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 27
- 239000008367 deionised water Substances 0.000 claims description 15
- 229910021641 deionized water Inorganic materials 0.000 claims description 15
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 15
- 239000000758 substrate Substances 0.000 claims description 15
- 239000004745 nonwoven fabric Substances 0.000 claims description 13
- 239000000416 hydrocolloid Substances 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 11
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 9
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical group OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 8
- 238000002845 discoloration Methods 0.000 claims description 8
- 239000000017 hydrogel Substances 0.000 claims description 8
- 229920000742 Cotton Polymers 0.000 claims description 7
- 239000007853 buffer solution Substances 0.000 claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 6
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 claims description 6
- 239000004744 fabric Substances 0.000 claims description 6
- 239000000835 fiber Substances 0.000 claims description 6
- 229920006264 polyurethane film Polymers 0.000 claims description 6
- 102000008186 Collagen Human genes 0.000 claims description 5
- 108010035532 Collagen Proteins 0.000 claims description 5
- 239000004698 Polyethylene Substances 0.000 claims description 5
- 229920001436 collagen Polymers 0.000 claims description 5
- 150000003961 organosilicon compounds Chemical class 0.000 claims description 5
- 229920000573 polyethylene Polymers 0.000 claims description 5
- 239000002696 acid base indicator Substances 0.000 claims description 4
- 235000010443 alginic acid Nutrition 0.000 claims description 4
- 229920000615 alginic acid Polymers 0.000 claims description 4
- 239000006260 foam Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 229910052709 silver Inorganic materials 0.000 claims description 4
- 239000004332 silver Substances 0.000 claims description 4
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 3
- 229940072056 alginate Drugs 0.000 claims description 3
- 150000003863 ammonium salts Chemical class 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 229920002647 polyamide Polymers 0.000 claims description 3
- 229920001296 polysiloxane Polymers 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- KSCAZPYHLGGNPZ-UHFFFAOYSA-N 3-chloropropyl(triethoxy)silane Chemical compound CCO[Si](OCC)(OCC)CCCCl KSCAZPYHLGGNPZ-UHFFFAOYSA-N 0.000 claims description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- 229920002101 Chitin Polymers 0.000 claims description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical class CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 claims description 2
- 239000004642 Polyimide Substances 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims description 2
- 229940069078 citric acid / sodium citrate Drugs 0.000 claims description 2
- XXBDWLFCJWSEKW-UHFFFAOYSA-N dimethylbenzylamine Chemical compound CN(C)CC1=CC=CC=C1 XXBDWLFCJWSEKW-UHFFFAOYSA-N 0.000 claims description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 2
- 229920002313 fluoropolymer Polymers 0.000 claims description 2
- 239000004811 fluoropolymer Substances 0.000 claims description 2
- 239000011505 plaster Substances 0.000 claims description 2
- 229920002492 poly(sulfone) Polymers 0.000 claims description 2
- 229920000728 polyester Polymers 0.000 claims description 2
- 229920001721 polyimide Polymers 0.000 claims description 2
- 229920000098 polyolefin Polymers 0.000 claims description 2
- 231100000241 scar Toxicity 0.000 claims description 2
- 229920005573 silicon-containing polymer Polymers 0.000 claims description 2
- 229920002554 vinyl polymer Polymers 0.000 claims description 2
- 239000008351 acetate buffer Substances 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 150000003377 silicon compounds Chemical class 0.000 claims 1
- 244000052616 bacterial pathogen Species 0.000 abstract description 8
- 230000002378 acidificating effect Effects 0.000 abstract description 3
- 238000012423 maintenance Methods 0.000 abstract 1
- 230000006641 stabilisation Effects 0.000 abstract 1
- 238000011105 stabilization Methods 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 description 51
- 206010052428 Wound Diseases 0.000 description 47
- 241000894006 Bacteria Species 0.000 description 18
- 230000008859 change Effects 0.000 description 17
- 230000000694 effects Effects 0.000 description 11
- 230000029663 wound healing Effects 0.000 description 11
- 241000588724 Escherichia coli Species 0.000 description 10
- 241000191967 Staphylococcus aureus Species 0.000 description 10
- 230000006378 damage Effects 0.000 description 9
- 208000015181 infectious disease Diseases 0.000 description 9
- 239000010410 layer Substances 0.000 description 9
- 230000003115 biocidal effect Effects 0.000 description 8
- 230000009102 absorption Effects 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 241000283011 Rangifer Species 0.000 description 6
- 241000194017 Streptococcus Species 0.000 description 6
- 206010048038 Wound infection Diseases 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 244000052769 pathogen Species 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 5
- 241000191940 Staphylococcus Species 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000005520 cutting process Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 229910052710 silicon Inorganic materials 0.000 description 5
- 239000010703 silicon Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000000853 adhesive Substances 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000004568 cement Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 229920001971 elastomer Polymers 0.000 description 4
- 230000001408 fungistatic effect Effects 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 229920001661 Chitosan Polymers 0.000 description 3
- 244000000626 Daucus carota Species 0.000 description 3
- 235000002767 Daucus carota Nutrition 0.000 description 3
- 206010059866 Drug resistance Diseases 0.000 description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 230000003385 bacteriostatic effect Effects 0.000 description 3
- 238000009395 breeding Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 229910052681 coesite Inorganic materials 0.000 description 3
- 229910052906 cristobalite Inorganic materials 0.000 description 3
- 230000002354 daily effect Effects 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 238000007654 immersion Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000003821 menstrual periods Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 229910021645 metal ion Inorganic materials 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- 229940068984 polyvinyl alcohol Drugs 0.000 description 3
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- HXMWJLVXIHYART-UHFFFAOYSA-M sodium;2-hydroxypropane-1,2,3-tricarboxylic acid;hydroxide;hydrochloride Chemical compound [OH-].[Na+].Cl.OC(=O)CC(O)(C(O)=O)CC(O)=O HXMWJLVXIHYART-UHFFFAOYSA-M 0.000 description 3
- 229910052682 stishovite Inorganic materials 0.000 description 3
- 229910052905 tridymite Inorganic materials 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- 208000005156 Dehydration Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 239000004964 aerogel Substances 0.000 description 2
- 230000004520 agglutination Effects 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 239000000022 bacteriostatic agent Substances 0.000 description 2
- 239000000648 calcium alginate Substances 0.000 description 2
- 235000010410 calcium alginate Nutrition 0.000 description 2
- 229960002681 calcium alginate Drugs 0.000 description 2
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- OBRMNDMBJQTZHV-UHFFFAOYSA-N cresol red Chemical compound C1=C(O)C(C)=CC(C2(C3=CC=CC=C3S(=O)(=O)O2)C=2C=C(C)C(O)=CC=2)=C1 OBRMNDMBJQTZHV-UHFFFAOYSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 230000000855 fungicidal effect Effects 0.000 description 2
- 239000000417 fungicide Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- STZCRXQWRGQSJD-GEEYTBSJSA-M methyl orange Chemical compound [Na+].C1=CC(N(C)C)=CC=C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 STZCRXQWRGQSJD-GEEYTBSJSA-M 0.000 description 2
- 229940012189 methyl orange Drugs 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000003071 parasitic effect Effects 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000004753 textile Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- XPFJYKARVSSRHE-UHFFFAOYSA-K trisodium;2-hydroxypropane-1,2,3-tricarboxylate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].[Na+].[Na+].OC(=O)CC(O)(C(O)=O)CC(O)=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O XPFJYKARVSSRHE-UHFFFAOYSA-K 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- LRWZZZWJMFNZIK-UHFFFAOYSA-N 2-chloro-3-methyloxirane Chemical compound CC1OC1Cl LRWZZZWJMFNZIK-UHFFFAOYSA-N 0.000 description 1
- KVYRCBOUKXJXDK-UHFFFAOYSA-N 3,4-dimethylphenazine-1,2-diamine hydrochloride Chemical compound Cl.C1=CC=CC2=NC3=C(C)C(C)=C(N)C(N)=C3N=C21 KVYRCBOUKXJXDK-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000157282 Aesculus Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- FRPHFZCDPYBUAU-UHFFFAOYSA-N Bromocresolgreen Chemical compound CC1=C(Br)C(O)=C(Br)C=C1C1(C=2C(=C(Br)C(O)=C(Br)C=2)C)C2=CC=CC=C2S(=O)(=O)O1 FRPHFZCDPYBUAU-UHFFFAOYSA-N 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 244000163122 Curcuma domestica Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 241000202296 Delphinium Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000692870 Inachis io Species 0.000 description 1
- 240000001549 Ipomoea eriocarpa Species 0.000 description 1
- 235000005146 Ipomoea eriocarpa Nutrition 0.000 description 1
- 241000124495 Paeonia delavayi Species 0.000 description 1
- 240000001090 Papaver somniferum Species 0.000 description 1
- 241000208181 Pelargonium Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 244000028344 Primula vulgaris Species 0.000 description 1
- 235000016311 Primula vulgaris Nutrition 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 240000004980 Rheum officinale Species 0.000 description 1
- 235000008081 Rheum officinale Nutrition 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 229910008051 Si-OH Inorganic materials 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- 229910006358 Si—OH Inorganic materials 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 229920004933 Terylene® Polymers 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- LDKDGDIWEUUXSH-UHFFFAOYSA-N Thymophthalein Chemical compound C1=C(O)C(C(C)C)=CC(C2(C3=CC=CC=C3C(=O)O2)C=2C(=CC(O)=C(C(C)C)C=2)C)=C1C LDKDGDIWEUUXSH-UHFFFAOYSA-N 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 241000722921 Tulipa gesneriana Species 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 241000673705 Viburnum tinus Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 125000005210 alkyl ammonium group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000002882 anti-plaque Effects 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- NUHCTOLBWMJMLX-UHFFFAOYSA-N bromothymol blue Chemical compound BrC1=C(O)C(C(C)C)=CC(C2(C3=CC=CC=C3S(=O)(=O)O2)C=2C(=C(Br)C(O)=C(C(C)C)C=2)C)=C1C NUHCTOLBWMJMLX-UHFFFAOYSA-N 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 238000001354 calcination Methods 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- NEHMKBQYUWJMIP-NJFSPNSNSA-N chloro(114C)methane Chemical compound [14CH3]Cl NEHMKBQYUWJMIP-NJFSPNSNSA-N 0.000 description 1
- 229960003405 ciprofloxacin Drugs 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- IQFVPQOLBLOTPF-HKXUKFGYSA-L congo red Chemical compound [Na+].[Na+].C1=CC=CC2=C(N)C(/N=N/C3=CC=C(C=C3)C3=CC=C(C=C3)/N=N/C3=C(C4=CC=CC=C4C(=C3)S([O-])(=O)=O)N)=CC(S([O-])(=O)=O)=C21 IQFVPQOLBLOTPF-HKXUKFGYSA-L 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 235000019503 curry powder Nutrition 0.000 description 1
- 238000001804 debridement Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- XJRPTMORGOIMMI-UHFFFAOYSA-N ethyl 2-amino-4-(trifluoromethyl)-1,3-thiazole-5-carboxylate Chemical compound CCOC(=O)C=1SC(N)=NC=1C(F)(F)F XJRPTMORGOIMMI-UHFFFAOYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 235000010181 horse chestnut Nutrition 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 238000002803 maceration Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 239000013335 mesoporous material Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- CEQFOVLGLXCDCX-WUKNDPDISA-N methyl red Chemical compound C1=CC(N(C)C)=CC=C1\N=N\C1=CC=CC=C1C(O)=O CEQFOVLGLXCDCX-WUKNDPDISA-N 0.000 description 1
- JCYPECIVGRXBMO-FOCLMDBBSA-N methyl yellow Chemical compound C1=CC(N(C)C)=CC=C1\N=N\C1=CC=CC=C1 JCYPECIVGRXBMO-FOCLMDBBSA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 235000006502 papoula Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- VLTOSDJJTWPWLS-UHFFFAOYSA-N pent-2-ynal Chemical compound CCC#CC=O VLTOSDJJTWPWLS-UHFFFAOYSA-N 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920000346 polystyrene-polyisoprene block-polystyrene Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009103 reabsorption Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000009938 salting Methods 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 239000007974 sodium acetate buffer Substances 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- PRZSXZWFJHEZBJ-UHFFFAOYSA-N thymol blue Chemical compound C1=C(O)C(C(C)C)=CC(C2(C3=CC=CC=C3S(=O)(=O)O2)C=2C(=CC(O)=C(C(C)C)C=2)C)=C1C PRZSXZWFJHEZBJ-UHFFFAOYSA-N 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- CZIRZNRQHFVCDZ-UHFFFAOYSA-L titan yellow Chemical compound [Na+].[Na+].C1=C(C)C(S([O-])(=O)=O)=C2SC(C3=CC=C(C=C3)/N=N/NC3=CC=C(C=C3)C3=NC4=CC=C(C(=C4S3)S([O-])(=O)=O)C)=NC2=C1 CZIRZNRQHFVCDZ-UHFFFAOYSA-L 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000015192 vegetable juice Nutrition 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000010148 water-pollination Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000005186 women's health Effects 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/07—Stiffening bandages
- A61L15/14—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Materials For Medical Uses (AREA)
Abstract
A kind of antibacterial dressing and the preparation method and application thereof.The antibacterial dressing composition includes organosilicon antibacterial agent, buffer stabilizer and solvent.The pH value of the antibacterial dressing composition is 3.5-6.5.The preparation method of the antibacterial dressing includes: that buffer stabilizer is added into organosilicon quaternary ammonium salt compound solution to adjust pH value as 3.0-6.9, it is 3.5-6.5 that the silica of amination processing, which is added, and adjusts pH value with buffer stabilizer, water is added in the solution and forms soak, it is added in soak and applies core, and adjusting soak pH value is 3.5-6.5.The pH value can control the slightly acidic environment of dressing composition, so that the surface of a wound or wound maintenance faintly acid of the dressing are attached, to have the function that stabilization checking growth of pathogenic bacteria.
Description
The present invention relates to the preparation methods and application of a kind of dressing more particularly to a kind of antibacterial dressing and the dressing.Belong to medical dressing technical field.
The defect of existing wound and surface of a wound diagnostic method:
Pathogenic bacteria are based on gram-positive bacteria (G+), including B groups of hemolytic streptococcus, staphylococcus, drug resistance golden staphylococci.The mode of common diagnosis infection clinical at present is blood routine examination.Blood routine is primarily to see leucocyte, if quantity, increasing proportion increase, it is believed that be bacterium infection.And the wound infection of part causes whole blood leucocyte to increase the one pathology time of needs, and is that could diagnose it after the pathogenic bacteria of infected wound reach certain amount by blood routine examination and be infected.But germ reproduction speed is that very fastly, a such as staphylococcus aureus can be multiplied into 17,000,000 in 24 hours.
Due to hydrogen ions influence metabolic process enzymatic activity, to influence most pathogen absorption of nutrient ingredients, therefore, the Reproduction Conditions and environmental pH of most pathogens are closely bound up.Such as: most pathogen breedings and existing optimum pH value are 7.2-7.6, such as: streptococcus optimum pH value is 7.4-7.6；Staphylococcus optimum pH value is 7.4.It is learnt through repetition test, streptococcus and staphylococcus decline with the acid pH that increases, and when pH drops to 5.5 or less, 89% streptococcus and staphylococcus breeding are inhibited and dead the growth of these unsuitable germs (environment at this time)；When pH drops to 4.5 or less, streptococcus and staphylococcus cannot grow and dead.It can be seen that, the environment of weak acid can destroy pathogenic bacteria metabolism, it is seen that maintain weakly acidic condition particularly important, due to hydrogen ions influence metabolic process enzymatic activity, to influence most pathogen absorption of nutrient ingredients, therefore the Reproduction Conditions of most pathogens and environmental pH are closely bound up.
When human skin is abraded, knife wound, burn and scald, tearing wound etc., it need to be protected in site of injury using medical grade dressing, avoid wound infection, accelerate wound healing.After skin damage, it will usually cause the exudation of a large amount of sepages, and the infection vulnerable to bacterial virus, cause to generate inflammation even tissue necrosis, and then seriously affect the normal operation of skin, at this point, the effect of wound dressing just seems very prominent.Existing medical dressing can be divided into traditional dressing and new pattern compress according to the material of dressing.Wherein, new pattern compress mainly has four classes, natural type dressing, medicinal dressing, synthesis type dressing, dressing organizational project class dressing.
Wherein, traditional dressing refers mainly to the skin substitutes to be stopped blooding in wound, burn and exanthemv to wound, again more；Include mainly common cotton gauze, bandage, degreasing cotton gauze, cotton pad and petrolatum gauze etc., this kind of dressing is clinically most widely used dressing, the advantages of be that production cost is low.But water absorbing properties are poor, and can generate adhesion with wound, the process of wound healing can form a scab, and need to be replaced frequently, and be easy to cause the tissue newly formed
It is easy to damage, when removing gauze, wound is also easy to produce secondary injury, while wound has the risk of dehydration.Such as dry gauze cannot be used for infected wound although can play the role of supervision covering wound, there is no facilitation to wound healing, sepage managerial ability is limited, adhesion wound, damage and cause bleeding, pain after patient's more change dressings again to newborn epithelial tissue.Oily yarn can play the role of adhesion wound containing vaseline or triglycerides；But there is no facilitation to the entire agglutination of wound, it is invalid to infected wound, sepage can be drained to two layers of dressing, sepage managerial ability is limited.The solvable gauze of traditional general fibre element without antibiotic property, need to smear antibiotic daily, then update and change gauze secondary injury easily also is caused to skin.
Natural type dressing mainly includes chitosan dressing, alginate dressing, the dressing of animal class and collagen dressing.Wherein, the series of biologic effect that chitosan has activation airframe systems, mediates airframe systems, improves the system function of phagocyte, and there are also antibacterial effects.But the drawbacks of chitosan gauze price is high, and it is prepared with Heavy environmental pollution.Seaweed salt medical dressing is mainly the dressing made of sodium alginate, alginic acid zinc or calcium alginate etc., and this kind of dressing has hydrophily and biocompatibility.Collagen type dressing is that dressing is prepared using the native protein that extracts from animal, and this kind of dressing is biodegradable and reabsorption, non-toxic, and can provide nutrition foundation for wound healing.But it equally exists expensive, collagen and purifies seriously polluted problem.
Drug class dressing includes interactive wound dressing, silver-colored dressing, calcium alginate dressings etc..General drug class dressing refers to addition antibacterial agent, such as sulfapryidine silver, Ciprofloxacin, to increase the antibiotic property of dressing.Silver ion can bind directly cell wall and kill bacterium in silver-colored dressing, control wound infection, and accelerating wound healing removes the peculiar smell generated by bacterium, is a kind of ideal anti-infective dressing；The disadvantage is that expensive, and metal ion is to using the patient to have certain health risk.Since the most raw material of drug class dressing is synthesis material, cannot biodegrade, and the problems such as synthetic antibiotic is also easy to produce drug resistance, antibiotic it is excessive using and bacterial drug resistance increase affect the effect of antibiotic in wound infection treatment.
The sixties in last century, British Winter propose " wet wound healing is theoretical ", i.e., wound is more advantageous to wound healing in the case where keeping moisture state, and cell travelling is helped to make skin smooth growth；People are allowed to have breakthrough understanding for the agglutination of wound.Therefore a series of moist wounds synthesis type casting products with better healing properties are developed, mainly includes film-type dressing, foam class dressing (foam dressing), Hydrogels dressing (hydrogel dressing), hydrocolloid class dressing (hydrocolloid dressing) etc..Such synthesis type dressing can replace damaged skin, and act on always to wound healing and skin lesion healing；External mechanical factor (such as foul, collision, inflammation) is such as resisted, pollution and chemical stimulation is resisted, prevents two degree of infection, prevents dry and body fluid from losing (electrolyte loss), preventing heat from losing.Also, other than carrying out protection comprehensively to wound, moreover it is possible to actively influence wound healing process by debridement, create the microenvironment for promoting wound healing.
Hydrogel medical dressing is prepared using some polyether polyols high-molecular compounds with strong absorptive structure, and this kind of macromolecular structure can form tridimensional network by being crosslinked；And itself has hydrophilic radical, can absorb sepage and be overlying on wound surface as one layer of hydrogel to protect wound；The wettability that wound can be automatically adjusted has a small amount of ability for absorbing sepage, does not glue wound, easily remove.And have and use closed moisturizing principle compared with the bearing hydrocolloid dressing of high water absorption multiplying power, hydrophilic sodium carboxymethylcellulose (CMC) particle oozes out the effect of being in contact, the surface of a wound with wound
Surface formed one layer of wet gelinite, persistently build moist environment, not with surface of a wound adhesion.It can be absorbed the normal saline solution for being equivalent to 20 times of own wt, but when encountering wound initial stage or larger compared with still showing slightly insufficient for gash, and influence its stickiness after moist wounds dressing moisture absorption, be easy to fall off it for disadvantage.Secondly, when encounter wound generate diffusate it is excessive when, wound because be in excessive moistening environment it is too long, be easy to produce exanthemv, or even cause bacterium infection, and then lead to wound secondary injury, dressing at this time is also limited for the absorbency of diffusate.Again, dressing used on the market at present does not have any warning function, and the infection conditions of wound can not be reminded to carry out more change dressings, can only artificially be replaced according to length of time.
Therefore, those skilled in the art is dedicated to developing a kind of new without antibiotic, antibacterial agent, fungicide or metal ion, the dressing with preferable fungistatic effect；Especially a kind of antibacterial dressing without chemical antimicrobials/bactericides, the antibacterial dressing can also have warning wound infection degree.
Summary of the invention
In view of the above drawbacks of the prior art, technical problem to be solved by the invention is to provide a kind of with the preferable antibacterial dressing for inhibiting bacterial growth effect, and the antibacterial dressing is without bacteriostatic agents or fungicide such as any antibiotic, metal ions.
To achieve the above object, the present invention provides a kind of novel antibacterial dressing, the standby inhibition bacterial growth function of matching in excellence or beauty with drug class dressing of the dressing especially can inhibit the growth of infectious bacteria.
The technical scheme of the invention to solve the technical problem is: a kind of antibacterial dressing, including antibacterial dressing composition, the pH value of the antibacterial dressing composition are 3.5-6.5, required pH can be obtained by the way that buffer is added in antibacterial dressing composition.In better embodiment of the invention, the pH value of antibacterial dressing composition is 4.4-5.5.
In a specific embodiment of the present invention, buffer is preferably glycine-HCI buffer, citric acid/disodium hydrogen phosphate buffer, citric acid/sodium citrate buffer, citric acid-sodium hydroxide-hydrochloride buffer or acetic acid/sodium acetate buffer etc..More preferably containing the buffer solution system of citric acid.Buffer can the amount of the antibacterial dressing composition weight of about 0.3%-2% exist, so as to stable pH system needed for keeping.
The pH environment that the present invention passes through control dressing, especially control the slightly acidic environment of dressing composition (deposited core), so that pasting any type of surface of a wound or wound and its pH maintains the faintly acid constant in surrounding (when no strong acid and strong base contacts) at least 36 hours of the dressing, to destroy the absorption of nutrient ingredients of wound circumference majority pathogenic bacteria, to have the function that stable inhibition growth of pathogenic bacteria.The dressing of present invention dressing composition containing subacidity is particularly suitable for inhibiting the growth of the infectious germ such as staphylococcus aureus, Escherichia coli, pylori.
Inventor has surprisingly found that, when antibacterial dressing contains silicon components, the presence that the pH of dressing composition can be stable enables fungistatic effect to maintain the longer time.Inventor estimates its principle when being containing organo-silicon compound, can be stablized by the synergistic effect between silicon components and quaternary ammonium salt ion and support the pH value of accompanying object rich in snubber elastomeric, keeps relative constant subacidity pH value to realize.
Dressing composition can exist for solution form, which can be used as the solution maceration extract that is spraying or can impregnating dressing applied to dressing.In a specific embodiment of the present invention, antibacterial dressing composition of the invention includes organosilicon antibacterial agent, buffer stabilizer, solvent.By mass percentage, it is preferable that organosilicon antibacterial agent content is 0.01%-3%,
It is more preferably 0.01%-1.5%, more preferably 0.01%-1%.When organosilicon antibacterial agent content is higher than 3%, antibacterial dressing of the invention is more stable, but its cost also greatly increases.Buffer stabiliser content is 0.001%-3%, preferably 0.01%-1.5%, more preferably 0.01%-1%.
In a specific embodiment of the present invention, the organosilicon antibacterial agent mainly includes organosilicon quarternary ammonium salt compound and/or silica.In a preferred embodiment of the invention, organosilicon antibacterial agent is organosilicone quaternary ammonium salt compound and silica, and by mass percentage, the ratio of silica and organosilicone quaternary ammonium salt compound is preferably 1: 30-10: 1.
Although existing document report organosilicon quaternary ammonium salt has an excellent antibacterial bacteriostatic performance, especially to staphylococcus aureus, Escherichia coli and candida albicans for 24 hours after bacteriostasis rate all may be up to 95% or more, and it is safe and non-toxic, without causing enzyme reaction.Such as there is polysiloxanes absorption property on pure cotton sheeting of the patent report with benzyl dimethyl silicon propyl ammonium chloride side group and its have stronger bactericidal activity to Escherichia coli and staphylococcus aureus.It can also be thus widely applied on the materials high-grade fabric antibacterial and mouldproof such as cotton, terylene, polyamide fibre, such as underskirt underpants, towel, insole, socks antibacterial.But organosilicon quaternary ammonium salt is used for dressing and is not yet had been reported that.Also, it the use of the great advantage that organosilicon quaternary ammonium salt is antibacterial agent is that Environmental Safety is nontoxic, it is to no skin irritation and good anti-bacterial effect, lasting, washable.When using silicon as medium, its surface that ammonium cation group with bacteriostasis property can be forcefully adsorbed in bacterium, to change the permeability of bacteria cell wall, so that endobacillary enzyme, coenzyme and metabolic intermediate overflow, cause bacterial micro-organism dehydration dead, to have the function that antibacterial.
In the present invention, organosilicone quaternary ammonium salt compound is chosen as the organosilicone quaternary ammonium salt compound as antibacterial agent commonly used in the art, this is not particularly limited in the present invention, and those skilled in the art selection and deployment or can buy commercial known compound according to actual needs.Organosilicone quaternary ammonium salt compound is preferably mono-quaternaries, bi-quaternary ammonium salt, three quaternary ammonium salts, the multi-quaternary ammonium salt, hyperbranched quaternary ammonium salt of organo-silicon compound；Such as monoalkyltrimethyl ammonium salts, dialkyl dimethyl ammonium salt or monoalkyl monobenzyl dimethyl ammonium, the quaternary ammonium salt of trialkoxy silane etc.；The wherein alkyl that alkyl is carbon atoms 1~20.The organo-silicon compound for more preferably all being replaced by alkyl comprising four hydrogen atoms in ammonium ion and generating.Organo-silicon compound are preferably ethyl orthosilicate, 3- chloropropyl triethoxysilane etc..It is highly preferred that organosilicone quaternary ammonium salt compound is the N that U.S. Dow Corn-ing company develops, N- dimethyl-N-octadecyl base TSL 8330 quaternary ammonium salt (DC-5700).In the present invention, it is also possible to which organic titanic compound substitutes organosilicone quaternary ammonium salt compound, and the two fungistatic effect is similar, but from cost of manufacture, hence it is evident that organic titanic compound is higher than organosilicone quaternary ammonium salt compound.
In the present invention, silica is preferably mesoporous SiO of the aperture in 2nm-50nm range2；The mesoporous SiO that more preferable aperture is 20nm-50nm2, such as mesopore molecular sieve (MCM41).
Buffer stabilizer (pH stable agent) role of the invention is that pH value buffering is provided for antibacterial dressing of the invention, and the antibacterial dressing is enabled to stablize lasting holding pH 3.5-6.5.Buffer stabilizer is preferably triethanolamine.Solvent of the invention is preferably deionized water.
In one particular embodiment of the present invention, buffer solution system is the buffer system containing citric acid, and pH stable agent is triethanolamine.Wherein, it is entirely hydrionic compound that citric acid, which is the cation generated when ionizing in the solution,；With Zeolite synthesis, using long chain alkyl ammonium salt and matched organic silicon source ethyl orthosilicate, inorganic silicon are hydrolyzed
The silica solution in source forms effectively stable carrier.
Preferably, antibacterial dressing of the invention also has alarm function, for a kind of antibacterial dressing of discoloration, that is, can be used to the sensing wound dressing for reminding wound infection.
In another better embodiment of the invention, antibacterial dressing also contains soda acid instruction component, when the antibacterial dressing for having alarm function is applied to the wound surface of skin, the effect of component can be indicated by soda acid, color change after absorbing diffusate using dressing, reminds user to carry out the replacement of dressing.
Soda acid instruction component of the invention can be specifically chosen according to practical application, be not particularly limited.Such as soda acid instruction component can be one of reindeer moss, methyl orange, phenolphthalein or other natural acid-base indicators etc..Since dressing is in practical applications to the usage amount very little of indicator, thereby indicate that agent range of choice is wide, it is specific unlimited.It such as can also be the one or more of crystal violet, picric acid, methyl chloride, peacock green, cresol red, thymol blue, Xi Suhuang, dimethyl yellow, methyl orange, bromophenol blue, reindeer moss, Congo red, bromocresol green, methyl red, dibromophenolphthalein, bromocresol purple, bromthymol blue, dimethyl diaminophenazine chloride, phenol red, cresol red, phenolphthalein, thymolphthalein and titan yellow；Or selected from one or more of preserved carrot, blueberry, carrot, cherry, curry powder, delphinium petal, fish pelargonium petal, grape, the leaf of horse chestnut, laurustinus, onion, morning glory petal, Primula vulgaris, opium poppy petal, Paeonia delavayi, red autumnal leaves cabbage, carrot, rheum officinale, roseleaf, strawberry, tea, thyme, turmeric, tulip petals, violet petal and purple Koryo vegetable juice.
The characteristics of component itself is indicated due to soda acid, even those skilled in the art are according to the common knowledge of this field it is found that the soda acid instruction component of micro content can also change according to pH value of solution and be changed.Therefore, the content of soda acid instruction component is not particularly limited in the antibacterial dressing of discoloration of the invention.Preferably, the weight content of soda acid instruction component is 0.001%-10%, more preferably 0.001%-1%；Content is conducive to cost control less.
As another object of the present invention, the present invention also provides a kind of preparation methods of antibacterial dressing that changes colour, specifically includes the following steps:
(1) deionized water (1000mL) is added into organosilicon quaternary ammonium salt compound solution (20-100mL)；Buffer, which is added, is adjusted to pH 3.0-6.9 simultaneously, at room temperature, which is placed in magnetic stirrer, obtains prefabricated acid solution；
(2) amination being added in prefabricated acid solution treated silica continues stirring and is placed on centrifuge centrifugation, and filtering filters off insoluble matter, acid-base indicator is added into filtrate, adjusts pH3.5-6.5 with buffer stabilizer；
(3) deionized water is added in solution obtained, forms soak, initial contaminating bacteria deposited core up to standard is added in soak, adjusted soak pH value and maintain to 3.5-6.5, impregnate；It drains, low temperature drying；Up to the antibacterial dressing of discoloration.
Wherein treated that silica refers to Nano-meter SiO_2 for amination described in step 22It is amination modified, the SiO of amino functional2I.e. functional mesoporous material has than SiO2Bigger specific surface area, controllable pore size and pore-size distribution, good thermal stability and mechanicalness.
In a particular embodiment, each group in dressing preparation can be calculated by calculating the pH value of immersion object dressing substrate
Divide dosage.
On the other hand, the present invention also provides a kind of antibacterial dressing that changes colour in the application for preparing Medical dressing equipment.
In the practical application of Medical dressing equipment, general dressing, which contains, absorbs bed course (being also deposited core), adhesion layer (some special dressing are free of this layer, such as bearing hydrocolloid dressing), substrate layer (fixed deposited core and contact surface).The above-mentioned antibacterial dressing of discoloration formed that impregnated by soak is the deposited core in applying, and after the deposited core cutting after immersion and will be adhered on dressing substrate and forms dressing.
One of in preferred specific embodiment, dressing substrate is selected from cotton, cellulose derivative class, polysulfones, polyamide-based, polyimide, polyesters, polyolefins, polyvinyls, silicon-containing polymer, fluoropolymer or chitin kind).It is highly preferred that dressing substrate is one of non-woven fabrics, polyurethane film, polyethylene film.
Preferably, Medical dressing equipment is selected from one of bandage, adhesive-bonded fabric dressing, gauze dressing, oily yarn dressing, inviscid dressing, transparent film dressing, hydrogel, bearing hydrocolloid dressing, alginate dressing, hydrophilic fibre, super-absorbert wound pad, dressing containing collagen, hypertonic salt dressing, foam dressing, carbon containing dressing, silver dressings, soft silicone dressing or liquid dressing.It is highly preferred that Medical dressing equipment is selected from one of bandage, bandage, hydrocolloid, hydrogel, scar plaster.
In practical applications, the antibacterial dressing of discoloration of the invention further includes the application on amenities and daily necessities.Purposes such as on sanitary napkin, and the purposes on the fabric of special purpose.
Women is in menstrual period, the skin of sensitive part most subject to damage or infection.Investigation shows to have 38% people can suffer from serious gynecological disease；73% women can feel local skin itch, cusalgia in menstrual period；80% or so women there is also the symptoms such as high fever, headache, abdominal pain；It is as caused by the sanitary napkin used that this is mostly.The reason is that female pelvic cavity, uterus, uterine neck vitro all communicate, such structure makes the reproductive system of women be subject to the invasion of extraneous causative agent.Especially intermenstrual period, the resistance decline of reproductive organs is more fragile than usual, if having used sub-standard sanitary napkin, is easy for infecting.There is nutriment abundant in menses, also therefore becomes " culture medium " that bacterium breeds without restraint.After one experiment shows that conventional sanitary napkin is used continuously 2 hours, surface layer total number of bacteria is up to 107 every square centimeter.Therefore, Yao Andu menstrual period select suitable sanitary napkin most important.Sanitary napkin is generally made of superficial layer, absorbed layer and bottom three parts.The absorbed layer that antibacterial dressing of the invention is used for sanitary napkin can reach to the effect for inhibiting bacterium, simultaneously, replacing construction can be also judged according to sanitary napkin color change when in use, energy is timely, effectively inhibits the growth of some germs, there is great meaning for women's health.
Antibacterial dressing of the invention applies also on daily necessities such as clothes, the textile fabric consisted of fibers, since the chemical structure of its more empty formula body form and high molecular polymer is conducive to microorganism attachment, become the good parasitic body of microorganism (such as intrinsic smell of bacterial decomposition human sweat, skin stench generated, corrupt substance, chemical substance) existence, breeding.Parasitic body can also pollute fiber other than the harm to human body, textile fabric after antibacterial dressing immersion treatment of the invention can eliminate these adverse effects significantly, people can be made to play antibacterial effect during everyday general purpose, achieve the effect that antibacterial especially by bacterium increment is inhibited.
Technical effect
Compared with the prior art, the advantages of the present invention are as follows: antibacterial dressing of the invention has superior absorption diffusate
Performance keeps wound moist, and wound healing mitigates pain, reduces dressing change frequency, can apply for a long time, waterproof, ventilative, inhibition pathogen, especially inhibition streptococcus and staphylococcic growth；With preferable antibacterial/antibacterial effect, wound climate can be detected in time, facilitates observation, can change prompt replacing construction in time according to product colour.Tests prove that, antibacterial dressing of the invention can reach and the use of nano silver is the same fungistatic effect of the dressing of bacteriostatic agent, since silver dressings can constantly release silver ion in use, and the national regulations such as America and Europe, silver-colored ppm is no more than 0.5PPM in water body, otherwise it will cause heavy metal pollution, huge destruction caused to water body.Also, if nano silver antimicrobials are absorbed by human body viscera, it can accumulate and lesion occurs, be detrimental to health.Therefore, antibacterial dressing of the invention is pollution-free, harmless, no cytotoxicity, nonirritant, extremely low sensitization；There is good commercial promise to silver-colored dressing is substituted.
It is described further below with reference to technical effect of the attached drawing to design of the invention, specific structure and generation, to fully understand the purposes, features and effects of the present invention.
In order to make the foregoing objectives, features and advantages of the present invention clearer and more comprehensible, below with reference to specific example, specific embodiments of the present invention will be described in detail.
In the following description, numerous specific details are set forth in order to facilitate a full understanding of the present invention, but the present invention can also take other modes to implement, those skilled in the art can do similar popularization under conditions of without prejudice to intension of the present invention, therefore the present invention is not limited by the specific embodiments disclosed below.
Secondly, " one embodiment " or " embodiment " referred to herein refers to a particular feature, structure, or characteristic that may be included at least one implementation of the invention.What different places occurred in the present specification is not necessarily referring to the same embodiment " in one embodiment ", nor the individual or selective embodiment mutually exclusive with other embodiments.
Embodiment 1
A kind of preparation of non-woven fabrics (for substrate) wound dressing
(1) preparation of organosilicone quaternary ammonium salt compound
In four-hole boiling flask, N, the mixture (mass ratio 3: 5) of N- diethylaminopropyl methyl dimethoxysilane and organic solvent is added；45 DEG C are warming up to, the mixture (mass ratio 1: 2) of epoxychloropropane and solvent is slowly added dropwise, is added dropwise, reaction a period of time；It is down to room temperature, rotary evaporation falls most solvents；It is washed 3 times with ether, is dried in vacuo 5h, obtains epoxy type organosilicon quaternary ammonium salt.
(2) amination handles silica
SiO2Material preparation: weighing 2g CTAB and be dissolved in hydrochloric acid solution (1.6mol/L, 75mL), and 4mL TMB is added and stirs evenly as oily phase.(40 DEG C) of a certain amount of ethyl orthosilicate (TEOS) water-bath reactions are slowly added dropwise for 24 hours, (110 DEG C) reactions are placed in autoclave again for 24 hours, after products therefrom is filtered, is washed for several times, it puts and spontaneously dries 2 days in air, aerobic calcining 5h can obtain mesoporous SiO to remove surfactant to gained white powder at 550 DEG C in Muffle furnace2Material.
The immobilization of amino: the SiO that TEOS hydrolysis generates2Work as addition there are a large amount of Si-OH key in skeleton surface
Ethyoxyl and SiO when ATES, in ATES2Condensation reaction occurs for the hydroxyl on surface, and amino can be grafted onto SiO2Surface.
(3) the organosilicone quaternary ammonium salting liquid (0.12g, 50mL) that will be prepared, is added in the deionized water of 500mL；It is added citric acid-sodium citrate buffer solution (0.2mol/L, 3.4mL) simultaneously, triethanolamine (1.5mL) adjusts pH to 3.0；At room temperature, which is placed in magnetic stirrer 4h, obtains prefabricated acid solution；
(4) amination treated silica (1g is added in prefabricated acid solution, pH≤4.5, aperture is 20nm), continue to stir 1h and is placed on the centrifuges of 2000 revolving speeds and is centrifuged, filter out insoluble matter, reindeer moss (0.01g, pH >=6.1) are added in the solution obtained after centrifugation；Acquired solution pH is 3.5 at this time；
(5) deionized water 1200mL is added in above-mentioned solution obtained, forms soak.Initial contaminating bacteria non-woven fabrics up to standard is added in soak and applies core (pH 8.8), it is about 3.5 that entire volume, which is dipped to soak pH value, then impregnates to take out after 30min and drain, and low temperature drying tunnel, which is dried, covers volume；
(6) it is required after non-woven fabrics obtained is applied core cutting according to preparation, is adhered on non-woven fabrics (pH=8.8) substrate using adhesive (pH=5.2) and forms the antibacterial dressing that changes colour.
(7) anti-microbial property test
Using E.coli (ATCC25922) and S.aureus (ATCC6538) as strains tested.Antibacterial test is carried out referring to the sample of ASTME2149:2001 " the active dynamic method of testing of anchorage antibacterial antiplaque agent " to not washed numbers different with washing.Sample is placed in the bacteria suspension of CFU105~106, after 37 DEG C of 4~12h of shaken cultivation, by suspension dilution certain multiple coating agar plate, its antibacterial effect is calculated by formula.
P (%)=[(Co-C)/Co] × 100%
In formula: P- Bacteria suppression percentage；Clump count after the non-antimicrobial treatment object co-cultivation of Co-；Clump count after the co-cultivation of C- antibacterial.
Through detecting, gained non-woven fabrics change colour antibacterial dressing apply core bacteriostasis rate bacteriostasis rate be staphylococcus aureus: 90%, Escherichia coli: 92%, pylori: 90%.
Embodiment 2
A kind of preparation of polyurethane (for substrate) wound dressing
(1) amination of organosilicone quaternary ammonium salt compound and silica is handled with embodiment 1；
(2) the organosilicon quaternary ammonium salt DC-5700 solution (0.5g, 30mL) that will be prepared, is added in the deionized water of 500mL；It is added citric acid-sodium citrate buffer solution (0.2mol/L, 2.6mL) simultaneously, triethanolamine (1mL) adjusts pH to 4.4；At room temperature, which is placed in magnetic stirrer 2h, obtains prefabricated acid solution；
(4) amination treated silica (0.6g is added in prefabricated acid solution, pH≤4.5, aperture is 2nm), continue to stir 1h and is placed on the centrifuges of 2000 revolving speeds and is centrifuged, filter out insoluble matter, reindeer moss (0.01g, pH >=6.1) are added in the solution obtained after centrifugation；Acquired solution pH is 4.4 at this time；
(5) deionized water 1000mL is added in above-mentioned solution obtained, forms soak.It is added in soak
Initial contaminating bacteria polyurethane film non-woven fabrics (pH >=7.4) up to standard applies core, and it is 4.0-4.5 that entire volume, which is dipped to soak pH value, then impregnates to take out after 30min and drain, and low temperature drying tunnel, which is dried, covers volume；
(6) it is required after non-woven fabrics obtained is applied core cutting according to preparation, is adhered on polyurethane film (pH >=7.4) substrate using adhesive (pH=5.2) and forms the antibacterial dressing that changes colour.
Through detecting, the change colour bacteriostasis rate of antibacterial dressing of gained is staphylococcus aureus: 93%, Escherichia coli: and 91%, pylori: 89%.
Embodiment 3
A kind of preparation of polyethylene (for substrate) wound dressing
(1) amination of organosilicone quaternary ammonium salt compound and silica is handled with embodiment 1；
(2) the organosilicon quaternary ammonium salt DC-5700 solution (3.5g, 60mL) that will be prepared, is added in the deionized water of 500mL；It is added citric acid-sodium hydroxide-hydrochloride buffer (0.05mol/L, 1.6mL) simultaneously, triethanolamine (1mL) adjusts pH to 6.5；At room temperature, which is placed in magnetic stirrer 2h, obtains prefabricated acid solution；
(4) amination treated silica (1.2g is added in prefabricated acid solution, pH≤4.5, aperture is 50nm), continue to stir 1h and is placed on the centrifuges of 2000 revolving speeds and is centrifuged, filter out insoluble matter, reindeer moss (0.01g, pH >=6.1) are added in the solution obtained after centrifugation；Acquired solution pH is 6.5 at this time；
(5) deionized water 1000mL is added in above-mentioned solution obtained, forms soak.Initial contaminating bacteria polyethylene film non-woven fabrics (pH >=8.0) up to standard is added in soak and applies core, it is 6.0-6.5 that entire volume, which is dipped to soak pH value, then impregnates to take out after 30min and drain, and low temperature drying tunnel, which is dried, covers volume；
(6) it is required after non-woven fabrics obtained is applied core cutting according to preparation, is adhered on polyethylene film (pH >=8.0) substrate using adhesive (pH=5.2) and forms the antibacterial dressing that changes colour.
Through detecting, the change colour bacteriostasis rate of antibacterial dressing of gained is staphylococcus aureus: 94%, Escherichia coli: and 93%, pylori: 91%.
Embodiment 4
A kind of preparation of polyurethane (for substrate) wound dressing
(1) amination of silica is handled with embodiment 1；
(2) citric acid-sodium hydroxide-hydrochloride buffer (0.05mol/L, 1.5mL) is added into the deionized water of 500mL, triethanolamine (0.8mL) adjusts pH to 5.5；At room temperature, which is placed in magnetic stirrer 2h, obtains prefabricated acid solution；
(4) amination treated silica (2g is added in prefabricated acid solution, pH≤4.5, aperture is 10nm), continue to stir 2h and is placed on the centrifuges of 5000 revolving speeds and is centrifuged, filter out insoluble matter, reindeer moss (0.01g, pH >=6.1) are added in the solution obtained after centrifugation；Acquired solution pH is 5.5 at this time；
(5) deionized water 1000mL is added in above-mentioned solution obtained, forms soak.Initial contaminating bacteria polyurethane film non-woven fabrics (pH >=7.4) up to standard is added in soak and applies core, it is 5.0-5.5 that entire volume, which is dipped to soak pH value, then impregnates to take out after 30min and drain, and low temperature drying tunnel, which is dried, covers volume；
(6) it is required after non-woven fabrics obtained is applied core cutting according to preparation, is adhered on polyurethane film (pH >=7.4) substrate using adhesive (pH=5.2) and forms the antibacterial dressing that changes colour.
Through detecting, the change colour bacteriostasis rate of antibacterial dressing of gained is staphylococcus aureus: 94%, Escherichia coli: and 92%, pylori: 95%.
Embodiment 5
Change colour bacteriostatic hydrocolloid dressing
(1) by organosilicon quaternary ammonium salt DC-5700 solution, (0.12g, 4mL are added in the deionized water of 90mL.It is added citric acid (3.4g) simultaneously, triethanolamine (1.5mL) adjusts pH to 3.0-6.9 that the mixed solution is placed in magnetic stirrer 4h, obtains prefabricated acid solution at room temperature；
(2) amination being added in prefabricated acid solution treated silica (1g, pH≤4.5, aperture 30nm) continues 3000 revolving speed of centrifuge after stirring 1h and is centrifuged, filtering, and acid-base indicator (0.01g) is added in filtrate；
(3) it 1.5kg styrene-isoprene block copolymer, 2.3kg polyisobutene, 1.0kg pentalyn and the medical grade white oil of 1.2kg is weighed is put into vacuum kneader and normally mediate 1-2 hours, then vacuumize (vacuum degree 0.07MPa) again and mediate 1 hour.Investment temperature of reaction kettle rises to 140~170 DEG C, after dissolving completely, 37.65kg sodium carboxymethylcellulose is added, is then slowly added in reaction kettle, is stirred continuously, and after being mixed thoroughly, cool down deaeration, spare；
(4) by above-mentioned hydrocolloid rubber cement in mixer in 80 DEG C of stirring 30min, when temperature is down to 45 DEG C, be added (1) acquired solution, with rubber cement stir 20min.By the pH value of calculating (1) solution and hydrocolloid rubber cement, citric acid (3g) adjusts after mixing pH value to 3.5-6.5.20min is stirred with rubber cement.After, mixture is removed from mixer, moisture content is removed into low temperature drying tunnel, is coated on separate paper, average rate coating stamps out the discoloration bacteriostatic hydrocolloid dressing of different size.
Through detecting, the change colour bacteriostasis rate of antibacterial dressing of gained is staphylococcus aureus: 92%, Escherichia coli: and 94%, pylori: 95%.
Embodiment 6
Change colour antibacterial aerogel dressing
(1) quaternary ammonium salt solution (0.12g, 10mL) that epoxy group is reacted to synthesis quaternary ammonium salt structure with organic amine, is added in the deionized water of 80mL.Buffer citric acid 3.4g, which is added, is adjusted to pH 3.0-6.9 simultaneously, at room temperature, which is placed in magnetic stirrer 3h, obtains prefabricated acid solution；
(2) 1kg polyvinyl alcohol is put into 8.9L deionized water and is dissolved 20 minutes；It places into 90 DEG C of water and dissolves；Magnetic agitation 1 hour.The step cannot contact metal.
(3) it is added prefabricated acid solution after poly-vinyl alcohol solution (10g) room temperature, magnetic agitation 1 hour.Mixed solution is cast in mold and freezes molding in 12 hours, cryogenic temperature is at -20 DEG C.Then it thaws 2 hours at room temperature；It freezes 12 hours for -20 DEG C again, then thaw at RT 2 hours；Third time is placed in -20 DEG C and freezes 12 hours, third time thaw at RT 2 hours；4th -20 DEG C of freezings 12 hours, the 4th time thaw at RT 2 hours.By calculating prefabricated acidity
The pH value of solution and poly-vinyl alcohol solution, pH value is to 3.5-6.5 after citric acid adjusts mixing.Up to the antibacterial aerogel dressing that changes colour.
Through detecting, the change colour bacteriostasis rate of antibacterial dressing of gained is staphylococcus aureus: 95%, Escherichia coli: and 94%, pylori: 92%.
The preferred embodiment of the present invention has been described in detail above.It should be appreciated that the ordinary skill of this field according to the present invention can be conceived without creative work makes many modifications and variations.Therefore, all technician in the art, all should be within the scope of protection determined by the claims under this invention's idea on the basis of existing technology by the available technical solution of logical analysis, reasoning, or a limited experiment.
Claims (16)
- A kind of antibacterial dressing, which is characterized in that including antibacterial dressing composition, the antibacterial dressing composition is located in the buffer solution system that pH value is 3.5-6.5.
- Antibacterial dressing according to claim 1, it is characterised in that: the antibacterial dressing composition includes organosilicon antibacterial agent, buffer stabilizer, solvent.
- Antibacterial dressing according to claim 2, which is characterized in that by mass percentage, organosilicon antibacterial agent content is 0.01%-3%, and buffer stabiliser content is 0.001%-3%；Preferably, organosilicon antibacterial agent content is 0.01%-1.5%, it is highly preferred that organosilicon antibacterial agent content is 0.01%-1%.
- Antibacterial dressing according to claim 1 to 3, it is characterised in that: the buffer solution system is citric acid/disodium hydrogen phosphate, citric acid/sodium citrate or acetic acid/acetate buffer system.
- Antibacterial dressing according to claim 2, it is characterised in that: the organosilicon antibacterial agent is organosilicone quaternary ammonium salt compound and/or silica.
- Antibacterial dressing according to claim 1, it is characterised in that: the pH value of the buffer is 4.4-5.5.
- Antibacterial dressing according to claim 5, it is characterised in that: the silica is preferably mesoporous SiO of the aperture in 2nm-50nm range2；The mesoporous SiO that more preferable aperture is 20nm-50nm2。
- Antibacterial dressing according to claim 5, it is characterised in that: the organosilicon antibacterial agent is organosilicone quaternary ammonium salt compound and silica；By mass percentage, the ratio of the silica and organosilicone quaternary ammonium salt compound is 1: 30-10: 1.
- Antibacterial dressing according to claim 5, it is characterised in that: the organosilicone quaternary ammonium salt compound is mono-quaternaries, bi-quaternary ammonium salt, three quaternary ammonium salts, the multi-quaternary ammonium salt, hyperbranched quaternary ammonium salt of organo-silicon compound；The ammonium salt is monoalkyltrimethyl ammonium salts, dialkyl dimethyl ammonium salt or monoalkyl monobenzyl dimethyl ammonium；Wherein silicon compound is ethyl orthosilicate or 3- chloropropyl triethoxysilane.
- Antibacterial dressing according to claim 2, it is characterised in that: the buffer stabilizer is triethanolamine.
- - 6 any antibacterial dressing according to claim 1, it is characterised in that: the antibacterial dressing of the discoloration also contains soda acid instruction component.
- A method of preparing the antibacterial dressing as described in claim 1-6 is any, which comprises the following steps:(1) at room temperature, buffer is added into the aqueous solution of organosilicone quaternary ammonium salt compound and is adjusted to pH3.0-6.9, stir to get prefabricated acid solution；(2) amination treated silica is added in prefabricated acid solution, continues to stir 1-4h, be centrifuged, acid-base indicator is added to filtrate in filtering；(3) deionized water is added in solution obtained, forms soak, dressing substrate is added in soak, adjusted Soak pH value is saved to 3.5-6.5 to get the antibacterial dressing of discoloration.
- The preparation method of antibacterial dressing according to claim 12, it is characterized in that, the dressing substrate is one of non-woven fabrics, polyurethane film, polyethylene film, cotton, cellulose derivative class, polysulfones, polyamide-based, polyimide, polyesters, polyolefins, polyvinyls, silicon-containing polymer, fluoropolymer or chitin kind.
- A kind of described in any item antibacterial dressing of claim 1-11 are preparing the application in Medical dressing equipment.
- A kind of application of described in any item antibacterial dressing of claim 1-11 in amenities, daily necessities.
- Antibacterial dressing according to claim 14 is in the application for preparing Medical dressing equipment, it is characterized in that, the Medical dressing equipment is one of bandage, bandage, hydrocolloid, hydrogel, scar plaster, adhesive-bonded fabric dressing, gauze dressing, oily yarn dressing, inviscid dressing, transparent film dressing, hydrogel, bearing hydrocolloid dressing, alginate dressing, hydrophilic fibre, super-absorbert wound pad, dressing containing collagen, hypertonic salt dressing, foam dressing, carbon containing dressing, silver dressings, soft silicone dressing or liquid dressing.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2016/000269 WO2017197542A1 (en) | 2016-05-20 | 2016-05-20 | Antibacterial dressing, and preparation method and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109069687A true CN109069687A (en) | 2018-12-21 |
Family
ID=60324753
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201680079420.0A Pending CN109069687A (en) | 2016-05-20 | 2016-05-20 | A kind of antibacterial dressing and the preparation method and application thereof |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN109069687A (en) |
| WO (1) | WO2017197542A1 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109528631A (en) * | 2018-12-29 | 2019-03-29 | 南京神奇科技开发有限公司 | A kind of gynecological antibacterial hydrogel and preparation method thereof |
| CN115212339A (en) * | 2022-07-20 | 2022-10-21 | 浙江红雨医药用品有限公司 | Active carbon polyurethane foam dressing and preparation method thereof |
| CN119656359A (en) * | 2024-12-13 | 2025-03-21 | 福建恒安集团有限公司 | Antibacterial absorption core and preparation method thereof |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109550076B (en) * | 2018-12-08 | 2023-09-01 | 郑州和济生物科技股份有限公司 | Medical silicone ozone oil vaseline dressing and wound care patch based on dressing |
| CN111012736A (en) * | 2020-02-11 | 2020-04-17 | 福建蓝昊肽生物科技发展有限公司 | Application of sterile spray dressing for blocking novel coronavirus 2019-nCov |
| CN111714285B (en) * | 2020-06-29 | 2022-08-19 | 温州大学 | Layer-by-layer self-assembled film and preparation method thereof |
| CN113773525B (en) * | 2021-09-18 | 2022-06-07 | 安徽大学 | A kind of preparation method and application of molybdenum disulfide-loaded nano-silver antibacterial hydrogel |
| CN114230808B (en) * | 2021-12-20 | 2024-04-16 | 中国科学院重庆绿色智能技术研究院 | A method for preparing antibacterial gel using aminopolyethylene glycol as gel matrix |
| CN114432485A (en) * | 2022-02-15 | 2022-05-06 | 周建大 | pH-responsive quaternary ammonium salt antibacterial dressing and preparation method thereof |
| CN114775273B (en) * | 2022-04-13 | 2023-06-27 | 安徽弋尚纺织科技有限公司 | Pure cotton antibacterial fabric and processing technology thereof |
| CN115317674B (en) * | 2022-07-07 | 2023-11-14 | 广东省科学院生物与医学工程研究所 | Antibacterial drug-loaded material, preparation method thereof and application thereof in preparing catheter |
| CN115414523B (en) * | 2022-08-31 | 2023-09-12 | 五邑大学 | Hydrogel dressing and preparation method thereof |
| CN115814140B (en) * | 2022-12-06 | 2024-04-12 | 电子科技大学 | Antibacterial wound dressing with both drainage and anti-adhesion functions and preparation method thereof |
| CN115814141A (en) * | 2022-12-12 | 2023-03-21 | 广东省人民医院 | A kind of medical dressing with antibacterial and anti-adhesion functions and preparation method thereof |
| CN116285096B (en) * | 2022-12-16 | 2024-03-26 | 沪金(苏州)实业有限公司 | Long-acting antibacterial polypropylene container and manufacturing method thereof |
| CN116410513B (en) * | 2022-12-20 | 2025-08-08 | 武夷学院 | Bacterial cellulose/sodium alginate/SiO2Preparation method and application of composite sponge material |
| CN116549706A (en) * | 2023-05-10 | 2023-08-08 | 长沙聚源医疗科技有限公司 | PH-sensitive recombinant collagen sponge dressing and preparation method thereof |
| IT202300013872A1 (en) * | 2023-07-04 | 2025-01-04 | Dealfa S R L | ADVANCED DRESSING IN THE FORM OF A COLLAGEN SHEET CONTAINING CHITOSAN AND AZELAIC ACID MICROSPHERES FUNCTIONALIZED WITH OZONIZED OIL LOADED ON MESOPOROUS SILICA |
| CN117468229B (en) * | 2023-10-13 | 2025-07-01 | 苏州金莱特化纤有限公司 | Antibacterial bamboo charcoal fiber and preparation method thereof |
| CN118718083B (en) * | 2024-07-01 | 2025-02-11 | 山东融元康医疗科技有限公司 | A high-efficiency transdermal dressing and preparation method thereof |
| CN118949107B (en) * | 2024-10-21 | 2025-02-25 | 浙江大学医学院附属第一医院(浙江省第一医院) | Antibacterial dressing for promoting wound healing, preparation method and application method |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1148803A (en) * | 1994-06-01 | 1997-04-30 | 尤尼利弗公司 | Mild antimicrobial liquid detergent formulation |
| WO2004073566A1 (en) * | 2003-02-21 | 2004-09-02 | Menicon Co., Ltd. | Coating material for medical use |
| CN1543983A (en) * | 2003-11-21 | 2004-11-10 | 凌沛学 | Wound nursing medicinal composition |
| UA34086U (en) * | 2008-03-13 | 2008-07-25 | Институт химии высокомолекулярных соединений НАН Украины | Cmc-pur-an, bactericide foamed polyurethane dressing material for medical purposes |
| CN101478876A (en) * | 2006-03-28 | 2009-07-08 | 佐治亚-太平洋消费产品有限合伙公司 | Antimicrobial hand towel with time delayed color transition indicator and delayed water absorption rate |
| CN101970560A (en) * | 2008-01-08 | 2011-02-09 | 奎克-麦德技术公司 | Disinfectant alcohol-soluble quaternary ammonium polymers |
| CN103285028A (en) * | 2013-05-14 | 2013-09-11 | 陈美儿 | Composite antibacterial agent of chitosan and organosilicone quaternary ammonium salt and preparation method of composite antibacterial agent |
| CN104220043A (en) * | 2012-04-30 | 2014-12-17 | 金伯利-克拉克环球有限公司 | Foaming formulations and cleaning products comprising silicone polyesters |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105343926B (en) * | 2015-11-09 | 2018-12-07 | 广东泰宝医疗科技股份有限公司 | A kind of scar plaster and preparation method thereof containing nano silica |
-
2016
- 2016-05-20 CN CN201680079420.0A patent/CN109069687A/en active Pending
- 2016-05-20 WO PCT/CN2016/000269 patent/WO2017197542A1/en not_active Ceased
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1148803A (en) * | 1994-06-01 | 1997-04-30 | 尤尼利弗公司 | Mild antimicrobial liquid detergent formulation |
| WO2004073566A1 (en) * | 2003-02-21 | 2004-09-02 | Menicon Co., Ltd. | Coating material for medical use |
| CN1543983A (en) * | 2003-11-21 | 2004-11-10 | 凌沛学 | Wound nursing medicinal composition |
| CN101478876A (en) * | 2006-03-28 | 2009-07-08 | 佐治亚-太平洋消费产品有限合伙公司 | Antimicrobial hand towel with time delayed color transition indicator and delayed water absorption rate |
| CN101970560A (en) * | 2008-01-08 | 2011-02-09 | 奎克-麦德技术公司 | Disinfectant alcohol-soluble quaternary ammonium polymers |
| UA34086U (en) * | 2008-03-13 | 2008-07-25 | Институт химии высокомолекулярных соединений НАН Украины | Cmc-pur-an, bactericide foamed polyurethane dressing material for medical purposes |
| CN104220043A (en) * | 2012-04-30 | 2014-12-17 | 金伯利-克拉克环球有限公司 | Foaming formulations and cleaning products comprising silicone polyesters |
| CN103285028A (en) * | 2013-05-14 | 2013-09-11 | 陈美儿 | Composite antibacterial agent of chitosan and organosilicone quaternary ammonium salt and preparation method of composite antibacterial agent |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109528631A (en) * | 2018-12-29 | 2019-03-29 | 南京神奇科技开发有限公司 | A kind of gynecological antibacterial hydrogel and preparation method thereof |
| CN115212339A (en) * | 2022-07-20 | 2022-10-21 | 浙江红雨医药用品有限公司 | Active carbon polyurethane foam dressing and preparation method thereof |
| CN119656359A (en) * | 2024-12-13 | 2025-03-21 | 福建恒安集团有限公司 | Antibacterial absorption core and preparation method thereof |
| CN119656359B (en) * | 2024-12-13 | 2026-01-02 | 福建恒安集团有限公司 | An antibacterial absorbent core and its preparation method |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017197542A1 (en) | 2017-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109069687A (en) | A kind of antibacterial dressing and the preparation method and application thereof | |
| US7329417B2 (en) | Medical dressing comprising an antimicrobial silver compound | |
| CN103520764B (en) | Functional dressing, and preparation method and application thereof | |
| CA1247001A (en) | Microbistatic and deodorizing catamenial and hygienic devices | |
| KR101377569B1 (en) | Antimicrobial Wound Dressing and Preparing Method of the Same | |
| CN104906620B (en) | A kind of hydrogel antibacterial gauze dressing and preparation method thereof | |
| Thomas et al. | Testing dressings and wound management materials | |
| CN110237295B (en) | Anthocyanin alginate dressing | |
| ES2334330T3 (en) | INHOCUS ADHESIVE FOR SKIN PROVIDED WITH A SUBSTANCE OF DECREASE OF PH. | |
| CN103271794B (en) | Biological antibiotic based on bedsore wound is applied ointment or plaster | |
| CN109432481A (en) | A kind of polyurethane dressing of hemostatic and antibacterial and preparation method thereof | |
| CN104524625B (en) | A kind of antibacterial, sanitary protection device removing abnormal flavour and preparation method thereof | |
| CN107456321B (en) | A kind of nanometer silver antimicrobial sanitary napkin and its production method | |
| CN104436290B (en) | Functional dressing for inhibiting scar hyperplasia and preparation method thereof | |
| CN111686295A (en) | Seepage self-adjusting composite dressing and preparation method thereof | |
| HUP0300269A2 (en) | Antiseptic compress | |
| KR20110114195A (en) | Pet hydrogel patch mixed with inorganic materials and its manufacturing method | |
| CN107296975A (en) | A kind of antibacterial anti hemorrhagic based composite dressing for medical use and preparation method thereof | |
| MX2008000969A (en) | Biomaterials based on carboxymethylcellulose salified with zinc associated with hyaluronic acid derivatives. | |
| CN107617121A (en) | A kind of skin wound biology induced activity dressing and its preparation method and application | |
| CN107854716A (en) | A kind of antibacterial dehumidification type dressing patch and preparation method thereof | |
| CN114225093A (en) | Antibacterial dressing with composite function and preparation method thereof | |
| CN106947095A (en) | A kind of preparation method for wound healing antibacterial type hydrogel | |
| CN208448217U (en) | An antibacterial hydrogel dressing | |
| CN109875762A (en) | A kind of novel antibacterial adhesive bandage and the preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181221 |